The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Integrating Old and New Paradigms of G1/S Control
Open accessAbstract
Summary The Cdk-Rb-E2F pathway integrates external and internal signals to control progression at the G1/S transition of the mammalian cell cycle. Alterations in this pathway are found in the vast majority of human cancers and specific Cdk4/6 inhibitors are approved or in clinical trials for the treatment of diverse cancers. In the long-standing paradigm for G1/S control, Cdks inactivate Rb through phosphorylation, which releases E2F transcription factors to drive cell-cycle progression from G1 to S. However, recent observations in the laboratory and clinic challenge central tenets of the current paradigm and demonstrate that our understanding of the Rb pathway and G1/S control is still incomplete. Here, we integrate these recent findings with the previous paradigm to synthesize a current molecular and cellular view of the mammalian G1/S transition. A more complete and accurate understanding of G1/S control will ultimately lead to improved therapeutic strategies targeting the cell cycle in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 6×
“Rather than existing in a continuum of phosphorylation states, which results from progressive and successive phosphorylation by the G1 Cdks, Rb is present in discrete states.”
InfluentialPalbociclib and letrozole in advanced breast cancer
Finn, R. S., Martin, M., Rugo, H. S., Jones, S., Im, S.-A., Gelmon, K., Harbeck, N., Lipatov, O. N., Walshe, J. M., Moulder, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607303 · Cited by 3,007
mTOR at the nexus of nutrition, growth, ageing and disease
Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Sicinski, P. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,858
Control of cell cycle transcription during G1 and S phases
Bertoli, C., Skotheim, J. M., & de Bruin, R. A. M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3629 · Cited by 1,500
Self-citationOverall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
Turner, N. C., Slamon, D. J., Ro, J., Bondarenko, I., Im, S.-A., Masuda, N., Colleoni, M., DeMichele, A., Loi, S., Verma, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1810527 · Cited by 1,276
Treating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057
Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
Zhang, J., Bu, X., Wang, H., Zhu, Y., Geng, Y., Nihira, N. T., Tan, Y., Ci, Y., Wu, F., Dai, X., et al. (2018) · Nature · doi:10.1038/nature25015 · Cited by 1,013
Overall survival with ribociclib plus endocrine therapy in breast cancer
Im, S.-A., Lu, Y.-S., Bardia, A., Harbeck, N., Colleoni, M., Franke, F., Chow, L., Sohn, J., Lee, K.-S., Campos-Gomez, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903765 · Cited by 1,001
Sledge, G. W., Toi, M., Neven, P., Sohn, J., Inoue, K., Pivot, X., Burdaeva, O., Okera, M., Masuda, N., Kaufman, P. A., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.4782 · Cited by 991
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
Self-citationTargeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936
DeGregori, J., Kowalik, T., & Nevins, J. R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4215 · Cited by 919
Cyclin E-CDK2 is a regulator of p27Kip1.
Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M., & Clurman, B. E. (1997) · Genes & Development · doi:10.1101/gad.11.11.1464 · Cited by 911
The broken cycle: E2F dysfunction in cancer
Kent, L. N., & Leone, G. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0143-7 · Cited by 800
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745
Pardee, A. B., Dubrow, R., Hamlin, J. L., & Kletzien, R. F. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.003435 · Cited by 712
Spencer, S. L., Cappell, S. D., Tsai, F.-C., Overton, K. W., Wang, C. L., & Meyer, T. (2013) · Cell · doi:10.1016/j.cell.2013.08.062 · Cited by 698
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
Johnston, S., Martin, M., Di Leo, A., Im, S.-A., Awada, A., Forrester, T., Frenzel, M., Hardebeck, M. C., Cox, J., Barriga, S., et al. (2019) · npj Breast Cancer · doi:10.1038/s41523-018-0097-z · Cited by 685
Molecular mechanisms underlying RB protein function
Dick, F. A., & Rubin, S. M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3567 · Cited by 569
Self-citationLoss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Li, Z., Razavi, P., Li, Q., Toy, W., Liu, B., Ping, C., Hsieh, W., Sanchez-Vega, F., Brown, D. N., Da Cruz Paula, A. F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.006 · Cited by 508
Spring, L. M., Wander, S. A., Andre, F., Moy, B., Turner, N. C., & Bardia, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30165-3 · Cited by 468
Cyclin D activates the Rb tumor suppressor by mono-phosphorylation
Narasimha, A. M., Kaulich, M., Shapiro, G. S., Choi, Y. J., Sicinski, P., & Dowdy, S. F. (2014) · eLife · doi:10.7554/elife.02872 · Cited by 461
Quantitative evolutionary dynamics using high-resolution lineage tracking
Levy, S. F., Blundell, J. R., Venkataram, S., Petrov, D. A., Fisher, D. S., & Sherlock, G. (2015) · Nature · doi:10.1038/nature14279 · Cited by 460
Turner, N. C., Liu, Y., Zhu, Z., Loi, S., Colleoni, M., Loibl, S., DeMichele, A., Harbeck, N., André, F., Bayar, M. A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00925 · Cited by 449
Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival
Thornton, T. M., & Rincon, M. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.44 · Cited by 443
Wander, S. A., Cohen, O., Gong, X., Johnson, G. N., Buendia-Buendia, J. E., Lloyd, M. R., Kim, D., Luo, F., Mao, P., Helvie, K., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1390 · Cited by 429
On being the right (cell) size
Ginzberg, M. B., Kafri, R., & Kirschner, M. (2015) · Science · doi:10.1126/science.1245075 · Cited by 421
Barr, A. R., Cooper, S., Heldt, F. S., Butera, F., Stoy, H., Mansfeld, J., Novák, B., & Bakal, C. (2017) · Nature Communications · doi:10.1038/ncomms14728 · Cited by 403
Condorelli, R., Spring, L., O’Shaughnessy, J., Lacroix, L., Bailleux, C., Scott, V., Dubois, J., Nagy, R. J., Lanman, R. B., Iafrate, A. J., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx784 · Cited by 394
Cyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4†
Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5338 · Cited by 392
Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition
Álvarez-Fernández, M., & Malumbres, M. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.010 · Cited by 390
What is the restriction point?
Zetterberg, A., Larsson, O., & Wiman, K. G. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80067-0 · Cited by 351
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival
Wang, H., Nicolay, B. N., Chick, J. M., Gao, X., Geng, Y., Ren, H., Gao, H., Yang, G., Williams, J. A., Suski, J. M., et al. (2017) · Nature · doi:10.1038/nature22797 · Cited by 347
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J. E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y. E., Clark, A. B., et al. (2011) · Nature · doi:10.1038/nature10155 · Cited by 333
Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein’s C-Terminal Helix
Topacio, B. R., Zatulovskiy, E., Cristea, S., Xie, S., Tambo, C. S., Rubin, S. M., Sage, J., Kõivomägi, M., & Skotheim, J. M. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.03.020 · Cited by 305
Self-citationLukas, C., Sørensen, C. S., Kramer, E., Santoni-Rugiu, E., Lindeneg, C., Peters, J.-M., Bartek, J., & Lukas, J. (1999) · Nature · doi:10.1038/44611 · Cited by 284
PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast Cancer
Costa, C., Wang, Y., Ly, A., Hosono, Y., Murchie, E., Walmsley, C. S., Huynh, T., Healy, C., Peterson, R., Yanase, S., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0830 · Cited by 270
ERK-Mediated Mechanochemical Waves Direct Collective Cell Polarization
Hino, N., Rossetti, L., Marín-Llauradó, A., Aoki, K., Trepat, X., Matsuda, M., & Hirashima, T. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.011 · Cited by 252
Irreversible APC Cdh1 Inactivation Underlies the Point of No Return for Cell-Cycle Entry
Cappell, S. D., Chung, M., Jaimovich, A., Spencer, S. L., & Meyer, T. (2016) · Cell · doi:10.1016/j.cell.2016.05.077 · Cited by 240
Size control in mammalian cells involves modulation of both growth rate and cell cycle duration
Cadart, C., Monnier, S., Grilli, J., Sáez, P. J., Srivastava, N., Attia, R., Terriac, E., Baum, B., Cosentino-Lagomarsino, M., & Piel, M. (2018) · Nature Communications · doi:10.1038/s41467-018-05393-0 · Cited by 239
Gong, X., Litchfield, L. M., Webster, Y., Chio, L.-C., Wong, S. S., Stewart, T. R., Dowless, M., Dempsey, J., Zeng, Y., Torres, R., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.006 · Cited by 236
Hiratsuka, T., Fujita, Y., Naoki, H., Aoki, K., Kamioka, Y., & Matsuda, M. (2015) · eLife · doi:10.7554/elife.05178 · Cited by 229
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
Guiley, K. Z., Stevenson, J. W., Lou, K., Barkovich, K. J., Kumarasamy, V., Wijeratne, T. U., Bunch, K. L., Tripathi, S., Knudsen, E. S., Witkiewicz, A. K., et al. (2019) · Science · doi:10.1126/science.aaw2106 · Cited by 229
Self-citationCompeting memories of mitogen and p53 signalling control cell-cycle entry
Yang, H. W., Chung, M., Kudo, T., & Meyer, T. (2017) · Nature · doi:10.1038/nature23880 · Cited by 211
Finn, R. S., Liu, Y., Zhu, Z., Martin, M., Rugo, H. S., Diéras, V., Im, S.-A., Gelmon, K. A., Harbeck, N., Lu, D. R., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0751 · Cited by 201
Miller, J. J., Summers, M. K., Hansen, D. V., Nachury, M. V., Lehman, N. L., Loktev, A., & Jackson, P. K. (2006) · Genes & Development · doi:10.1101/gad.1454006 · Cited by 200
Cell cycle proliferation decisions: the impact of single cell analyses
Matson, J. P., & Cook, J. G. (2017) · The FEBS Journal · doi:10.1111/febs.13898 · Cited by 182
Genetically Encoded Tools for Optical Dissection of the Mammalian Cell Cycle
Sakaue-Sawano, A., Yo, M., Komatsu, N., Hiratsuka, T., Kogure, T., Hoshida, T., Goshima, N., Matsuda, M., Miyoshi, H., & Miyawaki, A. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.10.001 · Cited by 172
Endogenous Replication Stress in Mother Cells Leads to Quiescence of Daughter Cells
Arora, M., Moser, J., Phadke, H., Basha, A. A., & Spencer, S. L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.055 · Cited by 170
EMI1 switches from being a substrate to an inhibitor of APC/CCDH1 to start the cell cycle
Cappell, S. D., Mark, K. G., Garbett, D., Pack, L. R., Rape, M., & Meyer, T. (2018) · Nature · doi:10.1038/s41586-018-0199-7 · Cited by 168
Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division
Zatulovskiy, E., Zhang, S., Berenson, D. F., Topacio, B. R., & Skotheim, J. M. (2020) · Science · doi:10.1126/science.aaz6213 · Cited by 166
Self-citationThe Biosynthetic Basis of Cell Size Control
Schmoller, K. M., & Skotheim, J. M. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.006 · Cited by 145
Self-citationControl of the Restriction Point by Rb and p21
Moser, J. C., Miller, I., Carter, D., & Spencer, S. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722446115 · Cited by 135
A Code of Mono-phosphorylation Modulates the Function of RB
Sanidas, I., Morris, R. T., Fella, K. A., Rumde, P. H., Boukhali, M., Tai, E. C., Ting, D. T., Lawrence, M. S., Haas, W., & Dyson, N. J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.01.004 · Cited by 135
Start and the restriction point
Johnson, A., & Skotheim, J. M. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.010 · Cited by 133
Self-citationA Dynamical Framework for the All-or-None G1/S Transition
Barr, A. R., Heldt, F. S., Zhang, T., Bakal, C., & Novák, B. (2016) · Cell Systems · doi:10.1016/j.cels.2016.01.001 · Cited by 133
Ginzberg, M. B., Chang, N. W., D'Souza, H., Patel, N., Kafri, R., & Kirschner, M. W. (2018) · eLife · doi:10.7554/elife.26957 · Cited by 130
APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis
Schrock, M. S., Stromberg, B. R., Scarberry, L., & Summers, M. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.001 · Cited by 127
Multisite phosphorylation networks as signal processors for Cdk1
Kõivomägi, M., Örd, M., Iofik, A., Valk, E., Venta, R., Faustova, I., Kivi, R., Balog, E. R. M., Rubin, S. M., & Loog, M. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2706 · Cited by 124
Self-citationEvidence that the human cell cycle is a series of uncoupled, memoryless phases
Chao, H. X., Fakhreddin, R. I., Shimerov, H. K., Kedziora, K. M., Kumar, R. J., Perez, J., Limas, J. C., Grant, G. D., Cook, J. G., Gupta, G. P., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188604 · Cited by 124
Cyclin D1 Represses STAT3 Activation through a Cdk4-independent Mechanism
Bienvenu, F., Gascan, H., & Coqueret, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100795200 · Cited by 118
Transient Hysteresis in CDK4/6 Activity Underlies Passage of the Restriction Point in G1
Chung, M., Liu, C., Yang, H. W., Köberlin, M. S., Cappell, S. D., & Meyer, T. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.08.020 · Cited by 116
p38γ is essential for cell cycle progression and liver tumorigenesis
Tomás‐Loba, A., Manieri, E., González‐Terán, B., Mora, A., Leiva‐Vega, L., Santamans, A. M., Romero-Becerra, R., Rodríguez, E., Chocano, A. P., Feixas, F., et al. (2019) · Nature · doi:10.1038/s41586-019-1112-8 · Cited by 109
Temporal integration of mitogen history in mother cells controls proliferation of daughter cells
Min, M., Rong, Y., Tian, C., & Spencer, S. L. (2020) · Science · doi:10.1126/science.aay8241 · Cited by 109
Cyclin E overexpression impairs progression through mitosis by inhibiting APCCdh1
Keck, J. M., Summers, M. K., Tedesco, D., Ekholm‐Reed, S., Chuang, L.-C., Jackson, P. K., & Reed, S. I. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703202 · Cited by 103
A Precise Cdk Activity Threshold Determines Passage through the Restriction Point
Schwarz, C., Johnson, A., Kõivomägi, M., Zatulovskiy, E. A., Kravitz, C. J., Doncic, A., & Skotheim, J. M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.12.017 · Cited by 100
Self-citationStress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation
Yang, H. W., Cappell, S. D., Jaimovich, A., Liu, C., Chung, M., Daigh, L. H., Pack, L. R., Fan, Y., Regot, S., Covert, M. W., et al. (2020) · eLife · doi:10.7554/elife.44571 · Cited by 99
Restriction point regulation at the crossroads between quiescence and cell proliferation
Pennycook, B. R., & Barr, A. R. (2020) · FEBS Letters · doi:10.1002/1873-3468.13867 · Cited by 92
Switching Cdk2 On or Off with Small Molecules to Reveal Requirements in Human Cell Proliferation
Merrick, K. A., Wohlbold, L., Zhang, C., Allen, J. J., Horiuchi, D., Huskey, N. E., Goga, A., Shokat, K. M., & Fisher, R. P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.031 · Cited by 91
Positive Feedback Keeps Duration of Mitosis Temporally Insulated from Upstream Cell-Cycle Events
Araújo, A. R., Gelens, L., Malik‐Sheriff, R. S., & Santos, S. D. M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.018 · Cited by 90
A G1 Sizer Coordinates Growth and Division in the Mouse Epidermis
Xie, S., & Skotheim, J. M. (2020) · Current Biology · doi:10.1016/j.cub.2019.12.062 · Cited by 85
Self-citationHeldt, F. S., Barr, A. R., Cooper, S., Bakal, C., & Novák, B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715345115 · Cited by 82
Schade, A. E., Oser, M. G., Nicholson, H. E., & DeCaprio, J. A. (2019) · Oncogene · doi:10.1038/s41388-019-0767-9 · Cited by 80
On the Molecular Mechanisms Regulating Animal Cell Size Homeostasis
Zatulovskiy, E. A., & Skotheim, J. M. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.01.011 · Cited by 78
Self-citationProbing Mammalian Cell Size Homeostasis by Channel-Assisted Cell Reshaping
Varsano, G., Wang, Y., & Wu, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.057 · Cited by 76
Liu, S., Ginzberg, M. B., Patel, N., Hild, M., Leung, B., Li, Z., Chen, Y., Chang, N. W., Wang, Y., Tan, C., et al. (2018) · eLife · doi:10.7554/elife.26947 · Cited by 72
Naetar, N., Soundarapandian, V., Litovchick, L., Goguen, K. L., Sablina, A. A., Bowman-Colin, C., Siciński, P., Hahn, W. C., DeCaprio, J. A., & Livingston, D. M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.023 · Cited by 68
Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinases
Persky, N. S., Hernandez, D., Carmo, M. D., Brenan, L., Cohen, O., Kitajima, S., Nayar, U., Walker, A., Pantel, S., Lee, Y., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0358-z · Cited by 68
Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation
Cuitiño, M. C., Pécot, T., Sun, D., Kladney, R. D., Okano‐Uchida, T., Shinde, N., Saeed, R., Perez-Castro, A., Webb, A., Liu, T., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.004 · Cited by 67
Feedforward Regulation Ensures Stability and Rapid Reversibility of a Cellular State
Doncic, A., & Skotheim, J. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.014 · Cited by 63
Self-citationInactivation of p38 MAPK during liver regeneration
Campbell, J. S., Argast, G. M., Yuen, S. Y., Hayes, B. J., & Fausto, N. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.002 · Cited by 60
Keenan, S. M., Lents, N. H., & Baldassare, J. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310383200 · Cited by 59
Compartmentalization of a Bistable Switch Enables Memory to Cross a Feedback-Driven Transition
Doncic, A., Atay, O., Valk, E., Grande, A., Bush, A., Vasen, G., Colman‐Lerner, A., Loog, M., & Skotheim, J. M. (2015) · Cell · doi:10.1016/j.cell.2015.02.032 · Cited by 47
Self-citationOrgan Size Control Is Dominant over Rb Family Inactivation to Restrict Proliferation In Vivo
Ehmer, U., Zmoos, A., Auerbach, R. K., Vaka, D., Butte, A. J., Kay, M. A., & Sage, J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.025 · Cited by 40
Self-citationMartinsson, H.-S., Starborg, M., Erlandsson, F., & Zetterberg, A. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.01.023 · Cited by 39
Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells
Caillot, M., Bourgeais, J., Dakik, H., Costé, É., Mazure, N. M., Lelièvre, E., Coqueret, O., Hérault, O., Mazurier, F., & Sola, B. (2020) · Oncogenesis · doi:10.1038/s41389-020-00253-3 · Cited by 36
Yano, S., & Hoffman, R. M. (2018) · Cells · doi:10.3390/cells7100168 · Cited by 31
Cited by
Matthews, H. K., Bertoli, C., & de Bruin, R. A. M. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00404-3 · Cited by 1,506
Cell cycle regulation: p53-p21-RB signaling
Engeland, K. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00988-z · Cited by 1,274
Deng, S., Vlatkovic, T., Li, M., Zhan, T., Veldwijk, M. R., & Herskind, C. (2022) · Cancers · doi:10.3390/cancers14194874 · Cited by 62
Cyclers’ kinases in cell division: from molecules to cancer therapy
Milletti, G., Colicchia, V., & Cecconi, F. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01196-z · Cited by 39
Qi, W.-L., Li, H.-Y., Wang, Y., Xu, L., Deng, J.-T., Zhang, X., Wang, Y.-X., & Meng, L.-H. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01015-0 · Cited by 19
Metadata
- Authors
- Rubin, S. M., Sage, J., & Skotheim, J. M.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 80
- Issue
- 2
- Pages
- 183-192
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W3087573264
- Cited by
- 264
- References
- 91
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.